Navigation Links
Drug Production in Afghanistan: A Challenge for the International Community
Date:5/24/2010

MOSCOW, May 24 /PRNewswire-USNewswire/ -- The international forum "Drug Production in Afghanistan: A Challenge for the International Community" will be held in Moscow on June 9 and 10, 2010, at Russia's initiative.

Heads of the key global drug control agencies and leading drug enforcement experts will gather in Moscow for a conference initiated by the Russian News & Information Agency RIA Novosti. The idea is supported by Russia's State Anti-Drug Committee, the Council for Foreign and Defense Policy and the Institute of Demography, Migration and Regional Development.

"Drug production in Afghanistan and the trafficking that follows have become so acute a problem that it requires leading figures in drug control agencies and the expert community to come together and discuss joint solutions. This problem must be resolutely confronted by the international community and a broad antidrug coalition formed," said Viktor Ivanov, Chairman of the State Anti-Drug Committee of the Russian Federation.

According to Russia's Federal Service for Drug Control, about 100,000 people worldwide, including up to 30,000 Russians, die each year as a result of opiates produced in Afghanistan, more than the number of those killed by the Hiroshima bomb. Production of opium-based drugs has doubled in the world over the past decade. With annual production standing at 7 billion doses, about 90% of the total, heroin dominates the global drugs market. It is turning the world, countries throughout Europe and Asia, Russia included, into a drug-ridden breeding ground for crime. The $65 billion dollars of drug money is destabilizing the young democracies of Central Asia, through which the main drug routes run, and hinders the process of normalization in Afghanistan.

Participants in the Moscow forum will try to determine the points of shared interest between all concerned parties, creating a common foundation for the struggle against drug production and trafficking.

The forum will be attended by the heads of drug control and law-enforcement agencies from many countries, statesmen, politicians, experts, journalists and representatives of the UN, the Collective Security Treaty Organization (CSTO), NATO, the Shanghai Cooperation Organization (SCO) and other international organizations.

It will be held in the Conference Center of the Swissotel Krasnye Holmy. Press accreditation information will be available later.


'/>"/>
SOURCE Drug Production in Afghanistan: International Forum
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Still River Systems Announces Production Milestone for the Worlds Smallest High-Energy Proton Therapy Accelerator
2. Customer Elects to Forego Commercial Production of Product
3. Single-Use Sensor Product Family Enters High Volume Production
4. Safe Life Ramps Production Capacity of Comfortable, Breathable N95 Respirator Amid Worldwide Shortage
5. Pfenex Grants Exclusive License to Merck & Co., Inc. for the Production of Proteins for Undisclosed Vaccine Program
6. Worlds Only FDA Approved Home Needle Destruction Device is in Production
7. Simcere Pharmaceutical Group Announces Jiangsu Yanshens Voluntary Suspension of Production
8. National System Aims To Minimize Diversion of Cold and Allergy Medicine in Methamphetamine Production
9. DAVISCO Foods International, Inc. and MEGGLE Group Announce a Joint Venture for the Production of Pharmaceutical Lactose.
10. China-Biotics, Inc. Begins Trial Production at New Facility, Affirms 2010 Revenue Guidance
11. Dynatronics Appoints Douglas Sampson as Vice President of Production and Research & Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... 28, 2017 The U.S. Food and ... treat adults with moderate-to-severe eczema (atopic dermatitis). Dupixent ... controlled adequately by topical therapies, or those for ... be used with or without topical corticosteroids. ... to approving new and innovative therapies for patients ...
(Date:3/28/2017)... PHOENIX , March 28, 2017  Today, ... Pharmacy released a new white paper to ... use of latex in healthcare. Specifically, there is substantial confusion ... fact, the FDA has urged manufacturers to drop the term ... labels, because of the challenge to ensure a product is ...
(Date:3/28/2017)... March 28, 2017 The global ... landscape, with the top three companies, namely Shimadzu Corporation, ... a significant 49% of the overall market in 2015, ... vendor landscape is intensely competitive and has few players, ... market. These factors have restricted the entry of new ...
Breaking Medicine Technology:
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... ... in Wethersfield, Conn., has relocated its corporate headquarters to a new, more expansive ... , In October 2016, Qualidigm purchased a distressed office building in Wethersfield, ...
(Date:3/28/2017)... Billerica, MA (PRWEB) , ... March 28, 2017 ... ... instrument for direct measurement of corrosive ions found in power plant water and ... plant components such as turbines and boilers, leading to extensive maintenance and unplanned ...
(Date:3/28/2017)... ... , ... Columbus OH. Dr. Justin Harper, Founder of Juvly Aesthetics in Ohio ... country to sit on the 2017 National Advisory Board for Allergan’s Facial Aesthetics National ... helped propel the clinic from a small start-up to number 78 in the country ...
(Date:3/28/2017)... ... 28, 2017 , ... Prominant bariatric surgeon and well-known weight-loss ... offer the recently FDA-approved Obalon Balloon System to his patients. The Obalon is ... already comprehensive list of weight-loss services. Dr. Liu is proud to announce ...
(Date:3/28/2017)... ... March 28, 2017 , ... With expansion and efficiency in ... early March. , The seed processing plant opened in Marshallville in 2006, and a ... new office allows opportunity for transition of Patten Seed operations to the Middle Georgia ...
Breaking Medicine News(10 mins):